Skip to content

Study on intestinal microorganism and metabolites of chronic obstructive pulmonary disease (COPD) patients

Study on intestinal microorganism and metabolites of chronic obstructive pulmonary disease (COPD) patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062232
Enrollment
Unknown
Registered
2022-07-30
Start date
2022-08-05
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Health group:None

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The subjects volunteer to participate in the clinical trial and signed a written informed consent; 2. The subject can understand verbal and/or written descriptions, and observe all experimental requirements; 3. No gender limit, aged 18 to 70 years; 4. Subjects who meet the clinical presentation and diagnostic criteria for chronic obstructive pulmonary disease.

Exclusion criteria

Exclusion criteria: 1. Patients with autoimmune diseases, infectious diseases, complicated with serious primary diseases of the heart, liver, kidney and hematopoietic system; 2. Suffering from malignant neoplastic diseases; Patients with brain tumors or other advanced cancers; 3. Pregnant and lactating patients; 4. Have a history of drug abuse; 5. Delirious, dementia, various mental patients.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Metabonomics;

Secondary

MeasureTime frame
Blood routine test;Pulmonary function;Inflammatory factors;

Countries

China

Contacts

Public ContactChen Mei

Chengdu Fifth People's Hospital

738118482@qq.com+86 13880336152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026